Company / Operating Income
Cocrystal Pharma, Inc. Operating Income History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$14.2M
FY2021
5-year range
-$62.9M / -$2.6M
FY2017-FY2021
Trend
+70.6%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$63M to -$14M over the past 2 years.
Based on SEC 10-K filings.
-$14M in FY2021.
Improved from -$63M to -$14M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, operating income increased 70.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$14.2M | +70.6% |
| FY2020 | -$48.4M | +23.1% |
| FY2019 | -$62.9M | -2364.2% |
| FY2012 | -$2.6M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026